When helping the minority of patients may hurt the majority: The case for DPD phenotyping and 5-fluorouracil therapeutic drug monitoring. Issue 2 (February 2021) - Tron, C; Lemaitre, F; Boisteau, Emeric; Sourd, S Le; Lièvre, A